Teva Pharmaceutical Industries (TEVA) Capital Expenditures Growth (1y) (2010 - 2026)
Teva Pharmaceutical Industries (TEVA) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | -21.54% |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 881.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.28% |
| Dec 31, 2025 | 10.08% |
| Sep 30, 2025 | -8.11% |
| Jun 30, 2025 | -1.03% |
| Mar 31, 2025 | 2.42% |
| Dec 31, 2024 | 8.40% |
| Sep 30, 2024 | -0.67% |
| Jun 30, 2024 | -18.49% |
| Mar 31, 2024 | -10.79% |
| Dec 31, 2023 | -16.20% |
| Sep 30, 2023 | 22.13% |
| Jun 30, 2023 | -6.30% |
| Mar 31, 2023 | -11.46% |
| Dec 31, 2022 | -7.19% |
| Sep 30, 2022 | -16.44% |
| Jun 30, 2022 | 12.39% |
| Mar 31, 2022 | 4.67% |
| Dec 31, 2021 | -13.07% |
| Sep 30, 2021 | 2.10% |
| Jun 30, 2021 | -13.74% |